검색
Verona Pharma PLC
VRNA관심 목록에 추가
106.910USD
0.0000.00%
종가 06/18, 16:00（ET）시세는 15분 지연됩니다
73.55B시가총액
손실P/E TTM
자세한 내용은 Verona Pharma PLC 회사
Verona Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. It is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The Company's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The Company's wholly owned subsidiary is Verona Pharma, Inc.
Verona Pharma PLC 정보
종목 코드 VRNA
회사 이름Verona Pharma PLC
상장일Mar 30, 2005
CEODr. David S. Zaccardelli, Pharm.D.
직원 수209
유형Depository Receipt
회계 연도 종료Mar 30
주소Riverside
도시LONDON
증권 거래소NASDAQ Global Market Consolidated
국가United Kingdom
우편 번호SE1 2RE
전화442032834200
웹사이트https://www.veronapharma.com/
종목 코드 VRNA
상장일Mar 30, 2005
CEODr. David S. Zaccardelli, Pharm.D.
Verona Pharma PLC의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Andrew Fisher
Mr. Andrew Fisher
General Counsel
General Counsel
528.82K
+0.66%
Dr. Kathleen Rickard, M.D.
Dr. Kathleen Rickard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ben Harber
Mr. Ben Harber
Company Secretary
Company Secretary
--
--
Dr. Anders Ullman, M.D., Ph.D.
Dr. Anders Ullman, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Benjamin Lucas
Mr. Benjamin Lucas
Principal Executive Officer, Director
Principal Executive Officer, Director
--
--
Ms. Ebru Can Temucin
Ms. Ebru Can Temucin
Principal Financial Officer, Principal Accounting Officer, Director
Principal Financial Officer, Principal Accounting Officer, Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Andrew Fisher
Mr. Andrew Fisher
General Counsel
General Counsel
528.82K
+0.66%
Dr. Kathleen Rickard, M.D.
Dr. Kathleen Rickard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ben Harber
Mr. Ben Harber
Company Secretary
Company Secretary
--
--
Dr. Anders Ullman, M.D., Ph.D.
Dr. Anders Ullman, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Benjamin Lucas
Mr. Benjamin Lucas
Principal Executive Officer, Director
Principal Executive Officer, Director
--
--
Ms. Ebru Can Temucin
Ms. Ebru Can Temucin
Principal Financial Officer, Principal Accounting Officer, Director
Principal Financial Officer, Principal Accounting Officer, Director
--
--
자주 묻는 질문
Verona Pharma PLC의 상위 5대 주주는 누구인가요?
Verona Pharma PLC의 상위 5대 주주는 다음과 같습니다: Mr. Andrew Fisher
Verona Pharma PLC(VRNA)의 주식을 보유한 기관은 몇 개입니까?
2025Q3 기준으로, Verona Pharma PLC의 주식을 보유한 기관은 총 467곳이며, 이들이 보유한 주식의 총 가치는 약 76.61M로 전체 발행 주식의 88.88%를 차지합니다. 이는 2025Q2 대비 -7116945.00 증가한 수치입니다.
